- Home
- MARPS vs CODX Comparison
MARPS vs CODX Comparison
Compare MARPS & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARPS
- CODX
- Stock Information
- Founded
- MARPS 1956
- CODX 2013
- Country
- MARPS United States
- CODX United States
- Employees
- MARPS N/A
- CODX N/A
- Industry
- MARPS Oil & Gas Production
- CODX Medical/Dental Instruments
- Sector
- MARPS Energy
- CODX Health Care
- Exchange
- MARPS Nasdaq
- CODX Nasdaq
- Market Cap
- MARPS 8.6M
- CODX 9.8M
- IPO Year
- MARPS N/A
- CODX 2017
- Fundamental
- Price
- MARPS $4.76
- CODX $0.42
- Analyst Decision
- MARPS
- CODX Buy
- Analyst Count
- MARPS 0
- CODX 2
- Target Price
- MARPS N/A
- CODX $5.50
- AVG Volume (30 Days)
- MARPS 5.7K
- CODX 13.6M
- Earning Date
- MARPS 01-01-0001
- CODX 11-06-2025
- Dividend Yield
- MARPS 7.79%
- CODX N/A
- EPS Growth
- MARPS N/A
- CODX N/A
- EPS
- MARPS 0.36
- CODX N/A
- Revenue
- MARPS $1,036,019.00
- CODX $1,003,653.00
- Revenue This Year
- MARPS N/A
- CODX N/A
- Revenue Next Year
- MARPS N/A
- CODX $31.58
- P/E Ratio
- MARPS $12.92
- CODX N/A
- Revenue Growth
- MARPS N/A
- CODX N/A
- 52 Week Low
- MARPS $3.34
- CODX $0.23
- 52 Week High
- MARPS $7.90
- CODX $1.40
- Technical
- Relative Strength Index (RSI)
- MARPS 55.01
- CODX 56.81
- Support Level
- MARPS $4.45
- CODX $0.30
- Resistance Level
- MARPS $4.68
- CODX $0.72
- Average True Range (ATR)
- MARPS 0.11
- CODX 0.06
- MACD
- MARPS -0.00
- CODX 0.02
- Stochastic Oscillator
- MARPS 59.42
- CODX 28.32
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.